Congratulations to Dr Andrew Colebatch who has recently published an excellent melanoma paper, utilising biospecimens from the Melbourne Melanoma Project, in the Journal Oncotarget. Andrew, who was featured in the MMP Newsletter #5 in September 2015, has provided us with a brief description of the scientific paper’s findings:
Scientific Publications
Screening for reducing morbidity and mortality in malignant melanoma
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects on morbidity and mortality of screening for malignant melanoma in the general population.
Melanoma journal articles for July/August 2016
Coffee consumption and the risk of malignant melanoma in the Norwegian Women and Cancer (NOWAC) Study Marko Lukic, Mie Jareid, Elisabete Weiderpass and Tonje Braaten BMC Cancer201616:562 DOI: 10.1186/s12885-016-2586-5 Received: 11 April 2016 Accepted: 20 July 2016 Published: 29 July 2016 The inhibitory effect of…
Read More ProvectusAnnounces Publication Of Article On PV-10 For In-Transit Melanoma In Journal Of Surgical Oncology
KNOXVILLE, Tenn.–(BUSINESS WIRE)–Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus" or “The Company”), today announced that an article on the use of PV-10 for in-transit melanoma has been published by the Journal of Surgical Oncology. It expands on a presentation on the same topic given at the Royal Australasian College of Surgeons 85th Annual Scientific Congress, which was held 2-6 May 2016, in Brisbane, Australia.